Inosine Trial to End Early

Researchers at the Michael J Fox Foundation recently announced that SURE-PD3, a Phase III clinical trial evaluating the potential of Inosine to slow Parkinson's progression, will end earlier than planned...Read more

**Webinar** - Targeting the Genetics of Parkinson's

In this third in our collaborative webinar series with the Journal of Parkinson's and Parkinson's Movement, Professor Patrik Brundin, Dr Gaurav Gupta, Dr Ziv Gan-or Dr Roy Alcalay, Jonathon Silverstein and Ben Stecher discuss the genetics of Parkinson's...Read more

New Sub-types of Parkinson's Proposed

A UK-wide study involving over 2500 people with recently diagnosed Parkinson's has identified four novel 'clusters' or groupings based on their clinical features.Read more

A Vaccine for Parkinson's - Developments in Immunotherapy

When misfolded, the protein alpha-synuclein becomes toxic to neurons and is a key pathological culprit in Parkinson’s. It is therefore an important target for disease-modification. Immunotherapy in Parkinson's attempts to use immune cells, and specifically the antibodies they generate, to target misfolded alpha-synuclein to inactivate it.Read more

The SPHERE Parkinson's Measuring Project

An innovative Parkinson's measurement and monitoring project using wearable health apps and sensors set up in a home environment is being developed at the University of Bristol.Read more

The Power of the Parkinson’s Patient According to Tom Isaacs - By Soania Mathur

Soania Mathur was, like former President of CPT Tom Isaacs, diagnosed with Young Onset Parkinson's at just 27. For Soania, Tom’s core principles of supporting people with Parkinson’s in becoming active participants in the search for better treatments, key to finding a cure.Read more

The Cancer Enzyme Involved in Parkinson's

Researchers at the Johns Hopkins School of Medicine have published a research report that points not only towards a specific pathway of neurodegeneration for Parkinson's, but also highlights a therapeutic target for which clinically-approved drugs are already available.Read more

'Cooling' Inflamed Brains in Parkinson's

When cells in the body become unwell or injured, they release proteins that inform the body of their stricken situation. These activate the release of further signalling proteins called inflammasomes...Read more

The Epitomical 'Mover & Shaker'

A Special Issue of the European Journal of Neuroscience in memory of late President and Co-founder Tom Isaacs has been compiled by NECTAR and this article by Tom's wife Lyndsey heralds this collaboration...Read more

Gene Therapy Approaches for Parkinson's

Two biotech companies have recently presented updates in their gene therapy treatment trials. Read more...Read more

When Science and Art Combine: The Cure3 Exhibition for Parkinson's

Cure3 2018 is the second edition of this acclaimed exhibition devised by Artwise in partnership with Bonhams to raise awareness of Parkinson's and support the vital research of The Cure Parkinson’s Trust's (CPT). The 'cube' concept was borne out of a description by late CPT co-founder and President Tom Isaacs of living with Parkinson’s as feeling like 'being boxed in.’Read more

Article: Triggers, Facilitators, and Aggravators - Redefining Parkinson’s Disease Pathogenesis

A recently published opinion paper by Prof. Patrik Brundin and colleagues proposes a redefinition of the pathogenesis of Parkinsons into three progressive phases...Read more

The 2018 Tom Isaacs Charity Golf Day

On Thursday 18th October, 14 teams took to the beautiful course at Denham Golf Club for the Tom Isaacs Charity Golf Day, raising £6,821 for The Cure Parkinson’s Trust.Read more

The Grouse & Grape Luncheon 2018

The eighth annual Grouse & Grape Luncheon was held on Tuesday 9th October at the historic Spencer House, and attracted over 340 guests who helped raise £31,000 (net) for The Cure Parkinson's Trust.Read more

Type 2 Diabetes Linked to Higher Rate of Parkinson's

The study published in Neurology is the largest study to date on the link between the two conditions.Read more

CPT Featured in The Telegraph - 'Could we be on the brink of a Parkinson's breakthrough?'

There is a general feeling of positivity within the Parkinson's research community and this article captures this.Read more

Grand Challenges in Parkinson's 2018

'Grand Challenges in Parkinson’s Disease' brings together hundreds of scientists, clinicians and people with Parkinson’s to explore the latest Parkinson’s research. The 2018 theme was Non-Motor Symptoms.Read more

The Linked Clinical Trials Meeting 2018

The international Linked Clinical Trials committee met again in September for its annual assessment and evaluation of multiple drugs and compounds with the potential to modify Parkinson's. Find out more...Read more

Rallying to the Challenge 2018 – Facebook Live

Re-watch the Rallying to the Challenge Facebook Live panel discussion broadcast from this year's meeting at VARI with panellists discussing the theme of this year’s symposium – 'Non motor symptoms in Parkinson’s' touching on areas such as sleep, issues with sense of smell and the relationship of the gut to Parkinson’s.Read more

Dr Simon Stott joins The Cure Parkinson's Trust

The Cure Parkinson's Trust is delighted to welcome Dr Simon Stott as the newly appointed Deputy Director of Research. Simon joins the team on 1st October 2018.Read more